[replyThe use of bioresonance therapy in the treatment of chronic autoimmune thyroiditis and focal lesions against the background of chronic autoimmune thyroiditis

AUTHORS : Deeva T.S. | Gustomesova E.N. | Potapova I.N. | Cheshenkova E.V. | Gustomesova V.I.

RELEVANT UNIVERSITIES : Department of Hospital Therapy of N.N.Burdenko Voronezh State Medical Academy,
GUZ VOKB No. 1, Voronezh, Russia

YEAR : 2002 | Category : Type of application

Autoimmune thyroiditis (AIT) (Hashimoto’s goiter, lymphocytic thyroiditis) was first described by Hashimoto in 1912. The prevalence of the disease among the population ranges from 2 to 11%, and there has been an upward trend in recent decades. Autoimmune thyroiditis is a genetically determined disease that confirmed by the frequent occurrence of histocompatibility antigens HLA Rfive (with hypertrophic form) and HLA Beight (with atrophic form).

Hashimoto’s goiter is an organ-specific autoimmune disease. The disease is based on a partial genetic defect in immunological surveillance, which is carried out by suppressor lymphocytes. As a result, there is an unhindered multiplication of prohibited clones of T-lymphocytes directed against the protein substrate (antigen) of the follicular epithelium of the thyroid gland, which enter into an antigen-antibody reaction, causing destruction of the follicular epithelium.